Mark Stejbach

Insider Reports History

Location
C/O Tengion, Inc., 2900 Potshop Lane, Suite 100, East Norriton, PA
Signature
/s/ Mark S. Levine, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Stejbach:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 Direct
Flexion Therapeutics Inc Director Stock option (right to buy) 0 Nov 19, 2021 Direct

Insider Reports Filed by Mark Stejbach

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FLXN Flexion Therapeutics Inc Nov 19, 2021 7 -$107K 4 Nov 19, 2021 Director
FLXN Flexion Therapeutics Inc Jun 24, 2021 2 $0 4 Jun 28, 2021 Director